Articoli correlati a Preclinical Development Handbook: Toxicology: 2
Sinossi
A clear, straightforward resource to guide you through preclinical drug development
Following this book's step-by-step guidance, you can successfully initiate and complete critical phases of preclinical drug development. The book serves as a basic,comprehensive reference to prioritizing and optimizing leads, toxicity, pharmacogenomics, modeling, and regulations. This single definitive, easy-to-use resource discusses all the issues that need consideration and provides detailed instructions for current methods and techniques.
Each chapter was written by one or more leading experts in the field. These authors, representing the many disciplines involved in preclinical toxicology screening and testing, give you the tools needed to apply an effective multidisciplinary approach. The editor, with more than thirty years' experience working with pharmaceutical and biotechnology companies, carefully reviewed all the chapters to ensure that each one is thorough, accurate, and clear.
Among the key topics covered are:
*
In vitro mammalian cytogenetics tests
*
Phototoxicity
*
Carcinogenicity studies
*
The pharmacogenomics of personalized medicine
*
Bridging studies
*
Toxicogenomics and toxicoproteomics
Each chapter offers a full exploration of problems that may be encountered and their solutions. The authors also set forth the limitations of various methods and techniques used in determining the safety and efficacy of a drug during the preclinical stage.
This is a hands-on guide for pharmaceutical scientists involved in preclinical testing,enabling them to perform and document preclinical safety tests to meet all FDA requirements before clinical trials may begin.
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
Informazioni sull?autore
SHAYNE COX GAD, PhD, DABT, ATS, is the Principal of Gad Consulting Services. Dr. Gad has more than thirty years of experience as a toxicologist, statistical consultant, manager, and general consultant on research and development in the chemical, consumer product, contract testing, biotechnology, medical device, and pharmaceutical industries. He is the author of twenty-nine books and numerous papers, presentations, and other publications.
Dal risvolto di copertina interno
A clear, straightforward resource to guide you through preclinical drug development
Following this book's step-by-step guidance, you can successfully initiate and complete critical phases of preclinical drug development. The book serves as a basic,comprehensive reference to prioritizing and optimizing leads, toxicity, pharmacogenomics, modeling, and regulations. This single definitive, easy-to-use resource discusses all the issues that need consideration and provides detailed instructions for current methods and techniques.
Each chapter was written by one or more leading experts in the field. These authors, representing the many disciplines involved in preclinical toxicology screening and testing, give you the tools needed to apply an effective multidisciplinary approach. The editor, with more than thirty years' experience working with pharmaceutical and biotechnology companies, carefully reviewed all the chapters to ensure that each one is thorough, accurate, and clear.
Among the key topics covered are:
*
In vitro mammalian cytogenetics tests
*
Phototoxicity
*
Carcinogenicity studies
*
The pharmacogenomics of personalized medicine
*
Bridging studies
*
Toxicogenomics and toxicoproteomics
Each chapter offers a full exploration of problems that may be encountered and their solutions. The authors also set forth the limitations of various methods and techniques used in determining the safety and efficacy of a drug during the preclinical stage.
This is a hands-on guide for pharmaceutical scientists involved in preclinical testing,enabling them to perform and document preclinical safety tests to meet all FDA requirements before clinical trials may begin.
Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.
Risultati della ricerca per Preclinical Development Handbook: Toxicology: 2
Foto dell'editore
Preclinical development handbook. [edited by] Shayne Cox Gad.
Editore:
Hoboken, NJ, Wiley-Interscience, c., 2008
ISBN 10: 0470248467
ISBN 13: 9780470248461
Antico o usato
Rilegato
Prima edizione
Da: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Germania
Valutazione del venditore 4 su 5 stelle
1st ed. 1 online resource (1075 p.). Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Pharmaceutical Development Series. Sprache: Englisch. Codice articolo 45370HB
Quantità: 1 disponibili
Foto dell'editore
Preclinical Development Handbook: Toxicology
Editore:
Wiley-Interscience, 2008
ISBN 10: 0470248467
ISBN 13: 9780470248461
Antico o usato
Rilegato
Da: Wonder Book, Frederick, MD, U.S.A.
Valutazione del venditore 5 su 5 stelle
Condizione: Very Good. Very Good condition. A copy that may have a few cosmetic defects. May also contain light spine creasing or a few markings such as an owner's name, short gifter's inscription or light stamp. Bundled media such as CDs, DVDs, floppy disks or access codes may not be included. NOT AVAILABLE FOR SHIPMENT OUTSIDE OF THE UNITED STATES. Codice articolo A07L-00447
Quantità: 1 disponibili
Foto dell'editore
Preclinical Development Handbook - Toxicology
Editore:
John Wiley and Sons Ltd, 2008
ISBN 10: 0470248467
ISBN 13: 9780470248461
Antico o usato
Rilegato
Da: OM Books, Sevilla, SE, Spagna
Valutazione del venditore 5 su 5 stelle
Condizione: Usado - bueno. Codice articolo 9780470248461
Quantità: 1 disponibili